摘要
Tumors,due to their diversity and heterogeneity,pose a significant threat to human health.Multidrug resistance is a prevalent and grave issue in clinical treatment,resulting in treatment failure and cancer recurrence.This resistance renders conventional drug therapies ineffective,presenting a substantial challenge to human health and medical care.Exploring natural products as potential sources for anti-cancer drugs could lead to the development of innovative and efficacious cancer treatments.This article aims to investigate the health implications of natural products(such as paclitaxel,podophyllotoxin,homoharringtonine,camptothecin,and vinblastine)in the discovery of anti-cancer drugs while discussing the methods and progress made in researching novel anti-cancer drugs derived from natural products.The paper discusses the diversity,intricate structures,and target affinity of natural products along with their structural modification techniques,combination therapies utilization possibilities with prodrugs or nanoparticles.Additionally,considering the escalating multidrug resistance observed in tumors nowadays;certain natural products offer new insights and approaches for discovering effective anti-tumor drugs that are crucial for addressing global public health challenges.The challenges faced by natural products during drug development including issues related to bioavailability toxicity concerns as well as limited resources are examined thoroughly.Potential opportunities current issues along with future challenges are highlighted aiming at facilitating the clinical translation of original anti-cancer drugs using natural products.
基金
supported by the National Natural Science Foundation of China(grant number 22309103)
Natural Science Foundation of Shandong Province(grant numbers ZR2022MH162,ZR2022QE202)
PhD Research Start-up Foundation of Qufu Normal University(grant numbers 614901,615201)
the project of introduction and cultivation for young innovation talents in the colleges and universities of Shandong Province(grant number 614202).
